Ovid prices $75M IPO

Neurological disease company Ovid Therapeutics Inc. (NASDAQ:OVID) raised $75 million through the sale of 5 million shares at $15 in an IPO underwritten by Citigroup, Cowen, William Blair and JMP Securities. The price valued the company at $369 million. Ovid said it expects trading to begin Friday.

Earlier this week, the company said it hoped to sell 5 million shares at $15-$17. At the $16 midpoint, a sale of that many shares would have raised $80 million and valued the company at $393.6 million...